Dixon Hughes Goodman Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1K	Buy	+110	New	+$1.25K	﹤0.01%	826

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's RDY Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors opened a new position in Dr. Reddy's Laboratories (RDY) in Q1 2022: 110 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #826 among its holdings.

145 funds tracked by Wall St. Rank hold RDY as of Q1 2022.

Dixon Hughes Goodman Wealth Advisors held 110 shares of Dr. Reddy's Laboratories worth $1K as of Q1 2022.
Dr. Reddy's Laboratories was a new Dixon Hughes Goodman Wealth Advisors position in Q1 2022.
Dr. Reddy's Laboratories made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #826 holding.
145 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.